Listen to Martin Lush and Global Quality leader Anders Vinther as they discuss COVID-19 and the "return to normal" as offices open back up globally. 

In this podcast, expert John Johnson gives his top tips for communicating clearly and effectively during unprecedented and unpredictable times.

For too long in the pharma industry, those at the sharp end have been blamed for most deviations and unplanned quality incidents. Why? Because it’s quick and convenient. In this podcast, Martin Lush shares his advice on how to improve your SOPs and reduce human error. 

This podcast includes essential facts about habits and why any change creates a risk of 'error'. It includes some hints for success when it comes to changing your habits in the workplace. 

This podcast from Rachel Carmichael explores the expectations from the diverse guidance documents and give practical suggestions on addressing your needs.

In this short podcast, John Johnson gives a summary on the proposed changes to EudraLex Volume 4, Annex 1. John gives his insight into the key parts of the update and how these may affect you, as well as providing some interpretation on how the changes may be inspected or enforced by the regulatory bodies.

Excipient GMP certification is becoming an expectation of pharmaceutical excipient customers. Catch up on this podcast from NSF's expert Jim Morris. Jim describes key elements of the standard, which areas are often cited as weaknesses and strategies for conducting an effective GMP gap assessment of an excipient manufacturer.

Reviews and compares the 2011 FDA Guidance and the recently published EU CHMP and draft GMP Annex 15 requirements for Process Validation. 

Created in collaboration with the Indian Drug Manufacturers’ Association, this unique, internationally recognized and independently assessed program has been specifically designed for Indian companies who want to succeed in U.S. and European markets, providing you and your company with what it needs to succeed. Find out more about our advanced PQM program. 

This podcast covers the trends and priorities when assuring data integrity from the perspectives of the U.S. FDA, MHRA and other regulatory bodies.